Precision Medicines company

Precision Medicines is dedicated to improving the lives of cancer patients through developing novel targeted medicines.
Precision Medicines is a clinical stage biotechnology company focussed on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
The development programs are focused on cancer sub types using a precision or personalized medicine approach, whereby therapies are co-developed with companion biomarkers to target the specific drivers of cancers.
Technology: P4 Medicine
Industry: Personalized Medicine
Headquarters: Alderley Edge, Cheshire, United Kingdom
Founded Date: Undisclosed
Employees Number: Undisclosed
Funding Status: N/A
Investors Number: 1
Last Funding Type: Non-equity Assistance

Visit Website
Register and Claim Ownership